Medicalgorithmics signs a new contract worth at least USD 5.9 million with its second largest customer
Medicalgorithmics, a WSE-listed developer of an innovative platform and AI algorithms for ECG analysis, has signed a new agreement with its long-standing Canadian partner specializing in home Holter ECG monitoring. The customer will additionally order at least 2,000 Kardiobeat.ai devices offered by Medicalgorithmics. The cooperation, which will remain in force until March 2028, will provide the Company with revenues of at least USD 5.9 million during its term. At the same time, the signing of the new agreement results from the acquisition of the Canadian contractor by an American healthcare giant listed on the New York Stock Exchange, which plans to expand intensively in the Canadian market. This should have a positive impact on the dynamic growth of Medicalgorithmics’ business in Canada, as well as on the Company’s revenue potential.